FDA Guidance Explains DSCSA Verification Systems for Certain Drugs

International Pharmaceutical Regulatory Monitor
A A
The FDA issued draft guidance that outlines what the agency considers an ideal and robust verification system that’s also in line with legislative requirements.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00